2-acetylaminofluorene has been researched along with Adverse Drug Event in 2 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Excerpt | Relevance | Reference |
---|---|---|
" Thus, the overall metabolism of toxic chemicals in hepatocyte cultures seem to be closest to the in vivo situation in the earlier time periods after isolation." | 1.27 | Xenobiotic metabolism and toxicity in primary monolayer cultures of hepatocytes. ( Holme, JA, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Z | 1 |
Shi, Q | 1 |
Ding, D | 1 |
Kelly, R | 1 |
Fang, H | 1 |
Tong, W | 1 |
Holme, JA | 1 |
2 other studies available for 2-acetylaminofluorene and Adverse Drug Event
Article | Year |
---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Xenobiotic metabolism and toxicity in primary monolayer cultures of hepatocytes.
Topics: 2-Acetylaminofluorene; Animals; Biotransformation; Cells, Cultured; Cricetinae; Culture Techniques; | 1985 |